Chief executive to keep database
224 Chief executive to keep database
The chief executive must keep an electronic database (the monitored medicines database) to record information about the prescription and supply of monitored medicines.
The purposes of keeping the monitored medicines database are—
to promote safe practices for the therapeutic use of monitored medicines and reduce community harm caused by monitored medicines; and
to ensure particular health practitioners are complying with this Act, a corresponding law or any applicable requirements under the Health Practitioner Regulation National Law; and
to facilitate—
the assessment or investigation of health service complaints under the Health Ombudsman Act 2013; and
the investigation or monitoring of persons subject to actions or orders under that Act; and
to enable particular health practitioners to access the database to record and review information for the therapeutic treatment of persons; and
to facilitate evaluation and research into monitored medicines; and
to facilitate national consistency in the therapeutic use of monitored medicines; and
any other purpose prescribed by regulation.
This provision refers to the regulations (prescribed by regulation
). Made under this Act:
This Act’s bill:Explanatory memorandumSecond reading speech
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.